Analyst Moves: AMGN, FCX, AVP
This morning, Goldman Sachs upgraded shares of Amgen (AMGN) from neutral to buy as near-term catalysts could propel the stock higher. With the upgrade, Goldman set a $130 price target and added the stock to its Conviction Buy List.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here